Health in Sweden 1,104 indicators covering health for Sweden. IndicatorLatest Year10-yr change Rank New or unknown treatment history cases: Pulmonary, bacteriologically 201 2023 down 34.7% 141st Cholera case fatality rate 0 2015 — 37th Medical doctors not further defined 16,158 2022 up 45.6% 41st Life satisfaction vs life expectancy 83.26 2023 up 1.6% 21st Estimate of current cigarette smoking prevalence 4.0% 2030 down 43.7% 148th Estimate of current cigarette smoking prevalence (%) 4.1% 2030 down 43.8% 148th Number of children aged 6-59 months with anaemia 87.09 2019 up 31.1% 115th Prevalence of anaemia in children aged 6-59 months 14.6% 2019 up 20.7% 167th Number of deaths attributed to non-communicable diseases, by type of 23,084 2019 up 2.6% 52nd Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 — 132nd Mean hemoglobin level of children aged 6-59 months 121 2019 down 0.8% 12th Estimated number of MDR/RR-TB incident cases 17 2024 down 45.2% 133rd Mortality caused by road traffic injury 3.1 per 100,000 population 2019 down 24.4% 174th Mortality caused by road traffic injury, female 1.5 per 100,000 female population 2019 down 28.6% 173rd Mortality caused by road traffic injury, male 4.8 per 100,000 male population 2019 down 22.6% 173rd Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd Life expectancy - Regions 83.8 Years 2024 up 1.8% 3rd Ipv vaccine coverage 97 2024 down 2.0% 51st Hospital beds 18.99 2022 down 28.5% 94th Treatment success rate for patients treated for MDR-TB 87.0% 2022 up 4.8% 27th New leprosy case detection rate per 1 000 000 population 0.754 2024 — 94th Peri-neonatal mortality by age of mother and parity, by NUTS 2 region 333 2023 down 23.8% 15th Fetal, peri- and neonatal mortality rates by NUTS 2 region of 2.57 2023 down 33.4% 21st Bladder cancer death rate 2.09 2023 down 27.0% 47th Cancer death rates by type who db 2.09 2023 down 27.0% 47th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 95.0% 2025 — 49th International Health Regulations core capacity scores, SPAR version 90 2025 — 14th Health statistics - Regions (for 'Developer API') — Crude mortality 8.65 Per 1 000 inhabitants 2024 down 6.2% 28th Health status - Regions — Crude mortality rate 8.65 Per 1 000 inhabitants 2024 down 6.2% 28th Leprosy registered prevalence rate per 1 000 000 population 0 2024 — 121st Leprosy - Number of new leprosy cases among children 0 2024 — 69th Leprosy - Number of cases registered for treatment 0 2024 — 121st New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th Hospital discharges by diagnosis and NUTS 2 region, day cases, total 130,604 2021 down 9.2% 16th Hospital discharges by diagnosis and NUTS 2 region, day cases, total 70,672 2021 down 4.9% 16th Hospital discharges by diagnosis and NUTS 2 region, day cases, total 59,932 2021 down 13.8% 15th Hospital days of in-patients by NUTS 2 region - females - historical 3.60 million 2021 down 25.3% 12th Ipv1 number unvaccinated 4,438 2023 up 280.1% 109th Hospital days of in-patients by NUTS 2 region - males - historical 3.92 million 2021 down 10.6% 12th Hospital days of in-patients by NUTS 2 region - total - historical 7.51 million 2021 down 18.3% 13th Hospital discharges by diagnosis and NUTS 2 region, in-patients 1.36 million 2021 down 11.1% 13th Hospital discharges by diagnosis, NUTS 2 region, in-patients and 718,185 2021 down 13.9% 13th Hospital discharges by diagnosis and NUTS 2 region, in-patients 637,158 2021 down 7.7% 13th Hospital discharges by diagnosis and NUTS 2 region, day cases, per 1,254 2021 down 18.3% 21st Hospital discharges by diagnosis and NUTS 2 region, day cases, per 1,366 2021 down 13.5% 21st Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Age-standardized prevalence of current tobacco use among persons aged 20.3% 2024 down 28.0% 72nd Hospital discharges by diagnosis and NUTS 2 region, day cases, per 1,143 2021 down 23.2% 21st Liver cancer death rate 3.38 2023 down 2.1% 79th Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 13,012 2021 down 19.9% 18th Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 13,881 2021 down 21.6% 18th Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 12,155 2021 down 17.8% 19th Number of female leprosy new cases 0 2024 — 102nd National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 — 155th Number of prevalent tuberculosis cases 910 2014 up 42.2% 133rd Number of new G2D leprosy cases 0 2024 — 86th Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th Public health expenditure share gdp 9.34 2025 up 1.9% 4th Proportion of total government spending on essential services, health 14.6% 2024 up 6.2% 29th Reported rate of new cervical cancer cases 7.48 2022 down 5.1% 25th ← Previous Page 15 of 19 Next →